Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing the safety and efficacy of Altelyse with Actilyse in acute myocardial infarction
IRCT20190729044366N1Phase 3Completed
- Sponsor
- Arena Pharmaceuticals
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of tissue-plasminogen activator in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Arena Pharmaceuticals. Started Jun 2021; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on IRCT20190729044366N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190729044366N1.